NM_018723.4:c.1042C>G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_018723.4(RBFOX1):c.1042C>G(p.Pro348Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,582 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018723.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBFOX1 | NM_018723.4 | c.1042C>G | p.Pro348Ala | missense_variant | Exon 15 of 16 | ENST00000550418.6 | NP_061193.2 | |
RBFOX1 | NM_145893.3 | c.1158C>G | p.Leu386Leu | synonymous_variant | Exon 13 of 14 | ENST00000355637.9 | NP_665900.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBFOX1 | ENST00000550418.6 | c.1042C>G | p.Pro348Ala | missense_variant | Exon 15 of 16 | 1 | NM_018723.4 | ENSP00000450031.1 | ||
RBFOX1 | ENST00000355637.9 | c.1158C>G | p.Leu386Leu | synonymous_variant | Exon 13 of 14 | 1 | NM_145893.3 | ENSP00000347855.4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152152Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251102Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135706
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461312Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 726930
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152270Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74450
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1105C>G (p.P369A) alteration is located in exon 12 (coding exon 12) of the RBFOX1 gene. This alteration results from a C to G substitution at nucleotide position 1105, causing the proline (P) at amino acid position 369 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy Uncertain:1
This sequence change replaces proline with alanine at codon 369 of the RBFOX1 protein (p.Pro369Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine. This variant is present in population databases (rs538050088, ExAC 0.01%). This variant has not been reported in the literature in individuals with RBFOX1-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at